StockWatch
·

BACIL PHARMA LTD. Q3 FY26 Results

BACPHARQ3 FY26 Results
Filing
MetricValue (₹ Cr)Q2 FY26Q3 FY25
Revenue0.00
Total Income0.0617.5%2050.0%
Expenditure0.0330.7%60.5%
PBT0.04113.0%163.2%
Net Profit0.04184.1%163.2%
OPM—
NPM60.78%35.64pp
EPS0.03200.0%130.0%
View full financials

Informational and educational content only. Not investment advice.